COVID-19-associated pityriasis rosea in children: Case report and literature review.
COVID‐19
SARS‐COV‐2
child
cutaneous
pityriasis rosea
skin
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
17
05
2022
revised:
23
06
2022
accepted:
05
07
2022
entrez:
22
7
2022
pubmed:
23
7
2022
medline:
23
7
2022
Statut:
epublish
Résumé
Skin lesions are one of the Coronavirus disease 2019 (COVID-19) symptoms. Pityriasis rosea (PR) is a mucocutaneous manifestation that can occur following virus infections. Most of the PR lesions after COVID-19 infection were reported in adults. Herein, we report a child with PR lesions, and a literature review on 5 other case reports in children.
Identifiants
pubmed: 35865772
doi: 10.1002/ccr3.6096
pii: CCR36096
pmc: PMC9295678
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e6096Informations de copyright
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest regarding the publication of this paper.
Références
J Eur Acad Dermatol Venereol. 2016 Mar;30(3):544-5
pubmed: 25545307
Medicine (Baltimore). 2021 Apr 09;100(14):e25352
pubmed: 33832113
Australas J Dermatol. 2021 May;62(2):e333-e334
pubmed: 33216971
J Prev Med Hyg. 2020 Oct 06;61(3):E304-E312
pubmed: 33150219
Med Clin (Engl Ed). 2020 Sep 25;155(6):273
pubmed: 32923675
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437
pubmed: 32359180
BMJ Case Rep. 2020 Aug 11;13(8):
pubmed: 32784233
J Med Virol. 2021 Apr;93(4):1850-1851
pubmed: 32970319
Clin Case Rep. 2022 Jul 19;10(7):e6096
pubmed: 35865772
J Med Virol. 2022 Apr;94(4):1292-1293
pubmed: 34931329
Dermatology. 2016;232(4):431-7
pubmed: 27096928
Clin Dermatol. 2022 Sep-Oct;40(5):586-590
pubmed: 35093476
JAAD Case Rep. 2021 Jan;7:93-94
pubmed: 33195784